Callan Family Office LLC Has $589,000 Position in Hims & Hers Health, Inc. (NYSE:HIMS)

Key Points

• Callan Family Office LLC reduced its stake in Hims & Hers Health, Inc. by 46.2% in the first quarter, holding 19,918 shares worth $589,000 after selling 17,120 shares.
• Institutional investors and hedge funds own 63.52% of Hims & Hers Health, with notable increases by Envestnet Asset Management and Invesco Ltd. during the fourth quarter.
• The company reported a revenue of $544.83 million for the latest quarter, missing estimates and showing a 72.6% year-over-year growth, while its earnings per share fell short of expectations.

Callan Family Office LLC lessened its stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 46.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,918 shares of the company's stock after selling 17,120 shares during the period. Callan Family Office LLC's holdings in Hims & Hers Health were worth $589,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of HIMS. Envestnet Asset Management Inc. increased its stake in shares of Hims & Hers Health by 139.2% in the 4th quarter. Envestnet Asset Management Inc. now owns 78,686 shares of the company's stock valued at $1,903,000 after buying an additional 45,791 shares during the period. Invesco Ltd. boosted its holdings in Hims & Hers Health by 613.9% in the fourth quarter. Invesco Ltd. now owns 1,277,026 shares of the company's stock valued at $30,878,000 after acquiring an additional 1,098,148 shares during the last quarter. Legal & General Group Plc increased its position in Hims & Hers Health by 209.3% in the fourth quarter. Legal & General Group Plc now owns 572,263 shares of the company's stock worth $13,841,000 after purchasing an additional 387,225 shares during the period. Raymond James Financial Inc. acquired a new stake in Hims & Hers Health in the fourth quarter worth about $18,048,000. Finally, Summit Investment Advisors Inc. raised its holdings in Hims & Hers Health by 3.3% during the 4th quarter. Summit Investment Advisors Inc. now owns 19,853 shares of the company's stock worth $480,000 after purchasing an additional 628 shares during the last quarter. Institutional investors and hedge funds own 63.52% of the company's stock.

Analyst Upgrades and Downgrades

HIMS has been the topic of several recent research reports. Morgan Stanley reaffirmed an "equal weight" rating and issued a $40.00 target price on shares of Hims & Hers Health in a research note on Wednesday, June 11th. Needham & Company LLC restated a "hold" rating on shares of Hims & Hers Health in a report on Tuesday, August 5th. TD Cowen cut shares of Hims & Hers Health from a "buy" rating to a "hold" rating and reduced their price objective for the company from $44.00 to $30.00 in a research note on Tuesday, April 29th. Truist Financial lifted their target price on shares of Hims & Hers Health from $45.00 to $48.00 and gave the stock a "hold" rating in a report on Thursday, July 17th. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Hims & Hers Health in a research note on Wednesday, May 7th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $39.83.

Hims & Hers Health Price Performance

Shares of HIMS stock opened at $48.34 on Thursday. The company has a quick ratio of 4.46, a current ratio of 4.98 and a debt-to-equity ratio of 1.72. Hims & Hers Health, Inc. has a 12-month low of $13.47 and a 12-month high of $72.98. The firm has a fifty day moving average of $53.28 and a 200-day moving average of $45.32. The firm has a market capitalization of $10.82 billion, a price-to-earnings ratio of 60.43, a price-to-earnings-growth ratio of 3.04 and a beta of 2.08.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%. The business had revenue of $544.83 million for the quarter, compared to the consensus estimate of $550.06 million. During the same quarter in the prior year, the firm posted $0.06 earnings per share. The business's revenue was up 72.6% on a year-over-year basis. On average, equities research analysts forecast that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Insider Activity at Hims & Hers Health

In other Hims & Hers Health news, insider Patrick Harrison Carroll sold 60,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $53.58, for a total transaction of $3,214,800.00. Following the sale, the insider directly owned 169,940 shares in the company, valued at approximately $9,105,385.20. This trade represents a 26.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Oluyemi Okupe sold 23,107 shares of the company's stock in a transaction that occurred on Monday, June 23rd. The shares were sold at an average price of $47.25, for a total transaction of $1,091,805.75. Following the completion of the transaction, the chief financial officer owned 63,222 shares of the company's stock, valued at $2,987,239.50. This trade represents a 26.77% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 1,448,695 shares of company stock worth $76,677,046. 13.71% of the stock is owned by company insiders.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Want to see what other hedge funds are holding HIMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hims & Hers Health, Inc. (NYSE:HIMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.